About Us
Company Overview
We are an integrated pharmaceutical company based in India, involved across the entire pharmaceutical value chain from research and development to manufacturing, distribution, marketing and exports.
Incorporated in 2005, Innova Captab Limited has grown by leaps and bounds and over the past 19 years, we have expanded from modest beginnings to become a trusted partner for top 14 out of 15 Indian pharma companies, along with multiple other customers.
We operate five state-of-the-art with nine independent manufacturing blocks located in Baddi (Himachal Pradesh), Dehradun (Uttarakhand), Taloja (Maharashtra), and Kathua (Jammu), compliant with WHO-GMP, EU-GMP, and other key certifications. Our robust manufacturing capabilities and reliable supply chain ensure highly efficient operations. We uphold and adhere to the highest protocol of quality of production while ensuring better efficiency throughout our supply chain. Additionally, we have developed a new greenfield multipurpose plant in Kathua, Jammu to further enhance our capabilities and to enhance our innovation capabilities, we are developing a new Research and Development center in Panchkula, Haryana. Through this expansion, we look forward to enhancing our capabilities to 5 facilities with 9 independent manufacturing blocks.
Our foundation lies in our in house recognized Research and Development (R&D) by DSIR, which drives our product portfolio expansion. We take pride in our strong team, who are instrumental in delivering exceptional value through innovative and high-quality products.
As a responsible corporate entity, we continually strive to meet Environmental, Social & Governance (ESG) compliance requirements, encompassing legal compliance, ethical business conduct, quality and patient safety, human rights, labour practices, employee health, safety, sustainability, and environmental stewardship. Our commitment to these principles is reflected in a range of initiatives, such as preventive healthcare and sanitation, advancing education, supporting animal welfare, and uplifting socially and economically backward groups. We uphold stringent standards through our Code of Conduct, Whistleblower Policy, and comprehensive Quality Policy, which includes a detailed Quality Control Manual. Our dedication to environmental stewardship is outlined in our Environment Health & Safety (EHS) Policy and EHS Manual, and our proactive Risk Management Policy ensures the identification and mitigation of potential risks.
We are committed to sustainable growth by exploring new opportunities and focusing on value-added products with the anticipated growth of the Indian pharmaceutical sector in the medium to long term. We aim to be a reliable and sustainable partner for both domestic and global manufacturers.
Business Areas
Contract Development and Manufacturing Organization (CDMO)
CDMO services and products encompass large-scale manufacturing of generic products, delivering customized and effective solutions to our customers. We served over 190 CDMO customers in FY’24. We offer multiple oral solid dosage, dry powder injections, dry syrup, BFS, Large Volume Parenterals and respiratory respule products. We also specialize in complex delivery forms, such as modified and sustained-release tablets and capsules by incorporating cutting-edge technologies like nanotechnology.
Domestic Branded Generics
This includes development, manufacture, distribution and marketing of branded generic formulation products under our own brand names across India through online and offline channels. Our portfolio includes over 600 products, reaching approximately 150,000 retail pharmacies through a robust network of about 5,000 distributors.
International Branded Generics
Exporting branded generic products to 25 countries, focusing on emerging and semi-regulated international markets, while also expanding into regulated markets such as the UK and Canada.
Sharon Bio-Medicine Limited (Sharon)
Manufactures intermediates, Active Pharmaceutical Ingredients (APIs) and finished dosages. Sharon also offers contract manufacturing services catering to domestic and international markets, such as Canada, the United Kingdom, Europe, Australia, Central, and South America.
To be a global leader in pharmaceutical innovation, driven by our commitment to quality, accessibility and sustainability, while making a significant impact on global healthcare.
At Innova Captab, our mission is to pioneer breakthroughs in pharmaceutical research and development and manufacture high-quality, affordable medicines for communities worldwide.
Board of Directors
Manoj Kumar Lohariwala is the Chairman and Whole-Time Director of our Company. He holds a bachelor’s degree in Commerce from Mohta College, Sadulpur, Maharshi Dayanand Saraswati University, Ajmer, Rajasthan. He has approximately 27 years of experience in manufacturing and marketing pharmaceutical products.
Vinay Kumar Lohariwala is the Managing Director of our Company. He holds a bachelor’s degree in Mechanical Engineering from Engineering College, Kota, University of Rajasthan, Jaipur, Rajasthan. He has approximately 22 years of experience in manufacturing and marketing pharmaceutical products.
Jayant Vasudeo Rao is a Whole-Time Director of our Company. He holds a bachelor’s degree in Science (Chemistry) from Arts, Science and Commerce College, Panvel, University of Bombay, Maharashtra. He has approximately 19 years of experience in production management for pharmaceutical formulations. Prior to joining our Company, he served as Production Head at Ebers Pharmaceuticals Limited, Prophyla Biologicals Private Limited, Lexicon Biotech (India) Limited, Scott-Edil Pharmacia Limited and as General Manager – Production and Planning at Brooks Laboratories Limited.
Archit Aggarwal is a Non-Executive Director of our Company. He holds a bachelor’s degree in Business Administration from Swiss Business School, Switzerland. He has over 4 years of experience in marketing and manufacturing jewellery.
Shirish Gundopant Belapure is a Non-Executive Independent Director of our Company. He holds a bachelor’s degree in Pharmacy from Shivaji University, Kolhapur, Maharashtra, and a master’s degree in Pharmacy (Pharmacognosy) from Nagpur University, Maharashtra. He also completed a long-term diploma course in Business Management from Nagpur Management Association, Maharashtra. He has approximately 27 years of experience in the pharmaceutical industry. Prior to joining our Company, he served as Managing Director at Zydus Hospira Oncology Private Limited, President – Manufacturing (Formulations) at Zydus Lifesciences Limited and held positions at The Fairdeal Corporation (Private) Limited, Griffon Laboratories Private Limited, and Cyanamid India Limited.
Sudhir Kumar Bassi is a Non-Executive Independent Director on our Company’s Board. He holds a bachelor’s degree in Commerce from Multani Mal Modi College, Patiala, Punjabi University, Punjab, and a master’s degree in Business Administration (Finance) from Punjabi University, Punjab. He has approximately 32 years of experience in investment banking and capital markets. He is a member of SEBI’s Research Advisory Committee, Primary Markets Advisory Committee, and Municipal Bond Development Committee. He currently serves as an Executive Director at Khaitan & Co. Prior to joining our Company he served as Managing Director (Investment Banking) at Morgan Stanley India Company Private Limited and as Executive Director (Mergers and Acquisitions) at JM Morgan Stanley Private Limited.
Priyanka Dixit Sibal is a Non-Executive Independent Director on our Company’s Board. She holds a bachelor’s degree in Law and Social Legal Sciences from ILS Law College, University of Pune, Maharashtra, and is a member of the Bar Council of Maharashtra and Goa. She has approximately 12 years of experience in corporate commercial law and mergers and acquisitions. Prior to joining our Company, she worked at law firms including Trilegal and Cyril Amarchand Mangaldas. She also served as General Counsel and Chief Legal Officer at Agarsha Investment Manager Private Limited (‘Lumis’), an alternative investment platform, and currently holds the position of Senior Associate General Counsel at Sirion Labs Private Limited.
Mahender Korthiwada is a Non-Executive Independent Director on our Company’s Board. He holds a bachelor’s degree in Pharmacy from J.N. Medical College, Belgaum, Karnataka University, Dharwad, Karnataka. He has approximately 29 years of experience in the pharmaceutical industry, Prior to joining our Company he served as Director – Special Projects at Abbott Healthcare Private Limited and as General Manager – Generics and Institutional at Natco Pharma Limited.
Major Events and Milestones
-
2023
Acquired Sharon Bio-Medicine Limited through the Corporate Insolvency Resolution Process (CIRP) to further strengthen our pharmaceutical portfolio.
Listed on India Stock Exchanges (NSE and BSE) on December 29, 2023.
-
Commenced construction of a new greenfield manufacturing plant in Kathua, Jammu and Kashmir.
Commenced construction of Research and Development center in Panchkula, Haryana.
2022
-
2021
Expanded manufacturing capabilities of the General block to achieve current capacity levels.
-
Commenced operations at new manufacturing facility (General) in Baddi, Himachal Pradesh.
2017
-
2015
Incorporated Univentis Medicare Limited for strengthening the Company’s marketing operations and market presence.
-
Received first international accreditation, the Certificate of Good Manufacturing Practices (GMP) for cephalosporin products from the Ministry of Medical Services, Republic of Kenya.
2013
-
2010
Commenced operations at the new manufacturing facility (Cephalosporin) at Baddi, Himachal Pradesh. Crucial expansion in the Company’s manufacturing capabilities.
-
Established first manufacturing plant in Baddi, Himachal Pradesh.
2006
Key Awards & Accreditations
2023
- Renewal of GMP compliance certificate for manufacturing and packaging general pharmaceutical formulations from the Tanzania Medicines and Medical Devices Authority.
- Renewal of GMP compliance certificate from Pharmacy and Poison Board, Kenya.
2022
- Received GLP certificate for testing of beta-lactam and non-beta-lactam products from the Health and Family Welfare Department, Government of Himachal Pradesh.
- Received GMP certificate for manufacturing beta-lactam and non-beta-lactam products from the Health and Family Welfare Department, Government of Himachal Pradesh.
2021
- Received GMP certificate for the production, packing, and quality control of tablets, capsules, and external preparations from the Health and Family Welfare Department, Government of Himachal Pradesh.
- Received good laboratory practices (GLP) certificate for testing of tablets, capsules, and external preparations from the Health and Family Welfare Department, Government of Himachal Pradesh.
- Received GMP Compliance certificate for the manufacture of beta-lactam (cephalosporin) and non-beta-lactam products from the National Drug Authority, Uganda.
- Received GMP certificate for production, packing, and quality control of cephalosporin and general products from the Health and Family Welfare Department, Government of Himachal Pradesh.
- Received GMP certificate for manufacturing tablets, capsules, and external preparations from the Health and Family Welfare Department, Government of Himachal Pradesh.
- Received GMP compliance certificate for manufacturing and aseptic filling of vials of cephalosporin products vials from the Food, Medicine, and Health Care Administration and Control Authority of Ethiopia.
2020
- Received recognition for our in-house research and development units from the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.
2019
- Received GMP certificate for manufacture and packaging of general pharmaceutical formulations from the Tanzania Medicines and Medical Devices Authority.
- Received GMP compliance certificate for manufacturing operations of medicinal products from the Medicines Authority of Malta.
2018
- Received a registration certificate for cephalosporin products and general product production from the Ministry of Health and Population, Republic of Yemen.
- Received the foreign pharmaceutical manufacturing company registration certificate from the Ministry of Public Health, Islamic Republic of Afghanistan.